Skip to main content
eScholarship
Open Access Publications from the University of California

UC San Diego

UC San Diego Electronic Theses and Dissertations bannerUC San Diego

Development and Optimization of FRET and BRET TORCAR Reporters

Abstract

Mechanistic target of rapamycin complex 1 (mTORC1) integrates growth-factor, nutrient, energy, and stress signals to regulate cell growth and homeostasis. Because conventional endpoint assays cannot fully resolve the timing, subcellular organization, or cell-to-cell variability of mTORC1 signaling, I developed genetically encoded reporters for dynamic measurement of mTORC1 activity in living cells. First, I optimized a Förster resonance energy transfer (FRET) target of rapamycin complex activity reporter (TORCAR) by screening fluorescent-protein pairs, EV-linker lengths, short flexible-linker truncations, and target of rapamycin signaling motif configurations. The final FRET TORCAR2 reporter combines truncated mTurquoise2 and YPet with a WW phosphoamino acid-binding domain, a 116-amino-acid EV linker, an engineered mTORC1 substrate, selected flexible-linker truncations, and one C-terminal target of rapamycin signaling motif. Phospho acceptor mutation, inhibitor pretreatment, and acute Torin1 addition supported phosphorylation-dependent, mTOR-dependent, and reversible reporting. I next adapted existing laboratory bioluminescence resonance energy transfer (BRET) components to create a plate-reader TORCAR platform. I established within-well normalization, screened BRET EV-linker lengths, evaluated WW- and FHA1-based reporters in transiently transfected HEK293A cells, and generated a pooled stable WW-based reporter population in NIH3T3 cells. The BRET reporters produced stimulation-associated kinetic responses, defining an initial multiwell platform while identifying response magnitude and reproducibility as priorities for further optimization. Together, FRET TORCAR2 and BRET TORCAR provide complementary strategies for single-cell imaging and scalable kinetic measurement of mTORC1 activity.

Main Content

This item is under embargo until September 24, 2028.